Over 50% of Vietnamese Ovarian Cancer Patients Could Benefit from Gene Solutions’ HRD Insight Test: Latest Validation Data Presented at ESMO Asia 2024

Our study, presented at the ESMO Asia Congress 2024 (Singapore, December 6–8), highlights the potential of Gene Solutions’ HRD Insight test as a transformative tool for ovarian cancer patients in